The CD274 gene encodes the immune inhibitory ligand PD-L1, which binds to the PD-1 receptor, blocking T-cell activation to prevent autoimmunity, a mechanism also used by the tumor to escape immune surveillance [30]. This evidence concerns the gene CD274 and neoplasm.